List view / Grid view
14 March 2024 | By Drug Target Review
Join us for this webinar as we explore the role of organoids in advancing treatment of neurological disorders. Organoids, miniature 3D models of human organs, are at the forefront of neuroscience research, offering insights into the complexities of the human brain. In this webinar, esteemed experts will explore the latest…
The potential for brain organoids to develop consciousness is a key issue in neuroscience, which has prompted new ethical considerations.
Researchers elucidate the significant role of CDX2 in regulating stemness and differentiation, particularly in the proximal colon’s epithelial cells. This research encourages new combinations of existing drugs, that inhibit both the BRAF and KRAS genes, to be explored.
Using an advanced human heart organoid system, researchers found the contributing factors to the condition and possible therapeutic compounds.
A new study proves that organoid drug testing is highly accurate at predicting effective treatments and finds a novel therapeutic option.
Researchers have made surprising and important findings that may influence organoid and cell reprogramming studies.
Explore the history and trends of microscopy in cancer research and discover the latest cancer imaging solutions and techniques in this eBook.
Researchers found that ANG in its mutated form slows stem cell differentiation, resulting in neurodevelopmental defects in adult nerve cells.
Anthrobots derived from human tracheal cells could perform therapeutic work without initiating an immune response.
Tips and tricks for fully leveraging Advanced Flow Cytometry.
A 2D neuromuscular junction model enables high-throughput screening to discover new treatments for neuromuscular diseases.
The first multi-chamber cardioids derived from hiPSCs have enabled scientists to investigate heart development and defects.
NETs require epidermal growth factor to grow, meaning that inhibiting EGF receptors could treat these types of tumours.
Intestinal organoids allowed researchers to understand how Rnf43 and Daam1 influence the balance of stem cell renewal and differentiation.
Researchers have developed organoids with naturally occurring early-stage immune cells, which could lead to effective personalised treatment.
